ABELZETA INC.
4Patents
4Active
4Granted
56Portfolio score
Filing activity: Mar 28, 2019 → Dec 27, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12356981B2 | Cell freezing medium for clinical use | Chemistry; Metallurgy | 0 | Active |
| US12311022B2 | Bispecific chimeric antigen receptors targeting CD20 and BCMA | Chemistry; Metallurgy | 0 | Active |
| US12018293B2 | Method for large-scale preparation of purified preparation of recombinant lentiviral vector at GMP grade | Physics | 0 | Active |
| US12338494B2 | Reagent and method for fluorescence quantitative real-time PCR detection of RCL | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.